Skip to main content
  • Home
  • About Us
  • Advisory Board
  • Advertise
  • Editorial Submissions
  • Contact Us
  • Subscribe to Newsletter

  • Follow me on Twitter
  • Friend me on Facebook
  • Connect with me on LinkedIn
  • Subscribe to me on YouTube
  • Subscribe to my RSS Feed

Menu

Skip to content
  • MedTech Economics
  • Policy
  • Manufacturing Execution
  • Product Design & Development
  • Quality & Compliance
  • Digital Health
  • Resource Library
  • Events & Webinars

MedTech Economics

Regenerative Medicine
January 13, 2016
Regenerative Medicine

The Steady Progress of Regenerative Medicine

By Maria Fontanazza

Changing the traditional healthcare model and moving from cure to prevention will take time.

Continue reading →

December 28, 2015

MedTech Predictions for 2016

By Maria Fontanazza

Not surprisingly, data science will reign over blockbuster drugs or devices.

Continue reading →

December 21, 2015

Device Tax on Hold for Two Years

By MedTech Intelligence Staff

The Senate vote is good news for industry, which has fought against the tax for years.

Continue reading →

December 10, 2015

Global mHealth Market to Hit $23.3 Billion by 2020

By MedTech Intelligence Staff

Trends in mHealth to be driven by increased smartphone penetration and prevalence of chronic diseases.

Continue reading →

Mobile Health adoption and connect medical devices, PricewaterhouseCoopers
December 9, 2015
Mobile Health adoption and connect medical devices, PricewaterhouseCoopers

The Patient-Consumer and Security Threats to Drive Medtech in 2016

By Maria Fontanazza

Industry consolidation, consumerized medical devices and cybersecurity are the top issues in the year ahead.

Continue reading →

Xiaomi Mi Band
November 16, 2015
Xiaomi Mi Band

Wearable Medical Device Trends in the Asian Markets

By Ames Gross

The rise in healthcare spending, jump in Western diseases, and increasing aging population are driving the market.

Continue reading →

November 12, 2015

American Diabetes Month: Fast Stats about the Disease

By Maria Fontanazza

This month MedTech Intelligence will cover the diabetes market, along with technologies and solutions that are improving patient quality of life.

Continue reading →

Maria Fontanazza and Michael Lohan, IDA Ireland, AdvaMed 2015
November 6, 2015
Maria Fontanazza and Michael Lohan, IDA Ireland, AdvaMed 2015

Ireland Remains Competitive in Medical Device Sector

By MedTech Intelligence Staff

With an established base of medtech companies and a strong workforce, Ireland remains a key player in the global supply chain.

Continue reading →

Joan Koerber-Walker and Maria Fontanazza, economic development in medtech, AdvaMed 2015
November 5, 2015
Joan Koerber-Walker and Maria Fontanazza, economic development in medtech, AdvaMed 2015

Finding the Right Ecosystem for MedTech Innovation

By MedTech Intelligence Staff

In order to keep innovation and manufacturing in the United States, device companies need federal and local support.

Continue reading →

October 30, 2015
MEDdesign

Science Fiction Meets Nano-Robots

By Klaus Jopp

A peek at the latest miniaturization trends, including nano-robots that transport therapeutics to tumors.

Continue reading →

Post navigation

  • Previous
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 38
  • Next

Upcoming Events & Webinars

No posts found.



On Demand Events & Webinars

No posts found.






Columns

October 8, 2026

MedTech Intelligence Industry Survey Research Methodology

By MedTech Intelligence Staff

The MedTech Intelligence Industry Survey is a primary research initiative designed to capture the perspectives of professionals working across the medical technology sector. The study is intended to examine the pressures, priorities, technology shifts, operational challenges, and strategic changes influencing MedTech organizations in 2026.

August 19, 2026

Devices are Getting Smarter, Making Materiovigilance Evolve Faster

By Dr. Padmalakshmi Jnaneshwar

According to Deloitte, only 22% of life sciences leaders say they have successfully scaled AI, and just 9% report achieving significant returns. For materiovigilance, this highlights the growing gap between execution and team expectations. Within this gap, fragmented data and manual processes continue to slow response times and increase compliance risk, creating a disconnect between the promise of real-time safety monitoring and operational reality. How can organizations close this execution gap and evolve materiovigilance from a reactive compliance function into a proactive, data-driven discipline?

August 10, 2026

What 524B and QMSR Change About Medical Device Risk

By Kaleb Averell
Balancing Cyber Risk

What 524B and QMSR actually require, in plain terms, including the post-market obligation that does not end at clearance? How both map to four kinds of exposure: cybersecurity, product liability, recall, and management liability. Where device makers are commonly unprepared against the new baseline, including the gap between cyber risk and product liability for software and devices.

August 10, 2026

Why Few MedTech Sales Teams Are Using AI Where It Matters Most

By Lee Smith

A MedTech survey revealed that most sales teams are not using AI for strategic purposes, such as identifying opportunities, prioritizing accounts, or research. Instead, AI is mostly deployed to complete administrative tasks, such as drafting emails and summarizing meetings. Why is more needed?

July 8, 2026

Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation

By MedTech Intelligence Staff
ZimmerBiomet

Zimmer Biomet will hire 500 professionals over the next three years for its new Bengaluru technology centre, expanding its AI, software engineering, and R&D capabilities as India strengthens its position as a global healthcare innovation hub.

June 1, 2026

MedTech In Focus: AI impact in healthcare

By MedTech Intelligence Staff

The most recent AI thought leadership published on MedTechIntelligence.com.

May 20, 2026

Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity

By Peter Justen

MTI Viewpoints Insights shared by industry relative to healthcare and the advancement of medical technology. Peter Justen is Founder and CEO of AmeriTrust Solutions. He works at the intersection of technology, data, and human-centered design to improve access to government...

May 20, 2026

The failure of the ‘usual suspects’ approach to life science recruitment

By Ivor Campbell

How has AI impacted the way in which companies recruit for senior specialists, particularly in highly niche roles in MedTech, biotech and pharmaceutical development? Finding the right people for these roles has never been harder.

TOPICS

  • Digital Health
  • MedTech Economics
  • Manufacturing Execution
  • Product Design & Development
  • Quality/Regulatory

Upcoming Events & Webinars

No posts found.

Contact Us

  • Advertising Opportunities
  • Editorial Submissions
  • General Inquiries
  • Privacy Policy
  • Cookie Policy
  • Sign Up for Newsletters

Innovative Publishing Company, Inc.

  • FoodSafetyTech
  • Food Safety Consortium Conference & Expo
  • MedTech Intelligence
  • Cannabis Industry Journal

© Copyright 2015 - 2026 Innovative Publishing Co., Inc., All Rights Reserved

Other Innovative Publishing Co., Inc. Sites: Food Safety Tech  |  Cannabis Industry Journal

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

MedTech Intelligence
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

We use tracking pixels that set your arrival time at our website, this is used as part of our anti-spam and security measures. Disabling this tracking pixel would disable some of our security measures, and is therefore considered necessary for the safe operation of the website. This tracking pixel is cleared from your system when you delete files in your history.

We also use cookies to store your preferences regarding the setting of 3rd Party Cookies.

Cookie Policy

A browser cookie is a small piece of data that is stored on your device to help websites and mobile apps remember things about you. Other technologies, including Web storage and identifiers associated with your device, may be used for similar purposes. In this policy, we say “cookies” to discuss all of these technologies.

Our Privacy Policy explains how we collect and use information from and about you when you use This website and certain other Innovative Publishing Co LLC services. This policy explains more about how we use cookies and your related choices.

How We Use Cookies

Data generated from cookies and other behavioral tracking technology is not made available to any outside parties, and is only used in the aggregate to make editorial decisions for the websites. Most browsers are initially set up to accept cookies, but you can reset your browser to refuse all cookies or to indicate when a cookie is being sent by visiting this Cookies Policy page. If your cookies are disabled in the browser, neither the tracking cookie nor the preference cookie is set, and you are in effect opted-out.

In other cases, our advertisers request to use third-party tracking to verify our ad delivery, or to remarket their products and/or services to you on other websites. You may opt-out of these tracking pixels by adjusting the Do Not Track settings in your browser, or by visiting the Network Advertising Initiative Opt Out page.

You have control over whether, how, and when cookies and other tracking technologies are installed on your devices. Although each browser is different, most browsers enable their users to access and edit their cookie preferences in their browser settings. The rejection or disabling of some cookies may impact certain features of the site or to cause some of the website’s services not to function properly.

Individuals may opt-out of 3rd Party Cookies used on IPC websites by adjusting your cookie preferences through this Cookie Preferences tool, or by setting web browser settings to refuse cookies and similar tracking mechanisms. Please note that web browsers operate using different identifiers. As such, you must adjust your settings in each web browser and for each computer or device on which you would like to opt-out on. Further, if you simply delete your cookies, you will need to remove cookies from your device after every visit to the websites. You may download a browser plugin that will help you maintain your opt-out choices by visiting www.aboutads.info/pmc. You may block cookies entirely by disabling cookie use in your browser or by setting your browser to ask for your permission before setting a cookie. Blocking cookies entirely may cause some websites to work incorrectly or less effectively.

The use of online tracking mechanisms by third parties is subject to those third parties’ own privacy policies, and not this Policy. If you prefer to prevent third parties from setting and accessing cookies on your computer, you may set your browser to block all cookies. Additionally, you may remove yourself from the targeted advertising of companies within the Network Advertising Initiative by opting out here, or of companies participating in the Digital Advertising Alliance program by opting out here.